News

A new systematic review of five meta-analyses confirms that ginger significantly reduces inflammation, lowers blood sugar and ...
A multi-institutional team led by Weill Cornell Medicine has received a five-year, $14.9 million grant from the National ...
New research from the Charles Perkins Centre at the University of Sydney has uncovered a new biological pathway that may help ...
One of the biggest challenges in cancer treatment is that certain cancers reappear after chemotherapy-and an aggressive type ...
Tumor electrophysiological abnormalities, characterized by membrane potential dysregulation, ion channel network remodeling, ...
Rheumatoid arthritis (RA) is an autoimmune disease that affects millions worldwide and can have a devastating impact on ...
Triple-negative breast cancer (TNBC) is an aggressive subtype lacking targeted therapies, making immunotherapy a promising ...
Researchers used whole-genome sequencing from diverse populations to identify 156 variants, including 133 novel ones, linked ...
The Atlantic diet blends Galicia’s culinary heritage with nutrient-rich foods that promote cardiovascular health and ...
The tumor microenvironment is not just a site of cancer growth—it is a high-stakes metabolic contest where tumor and immune cells vie for limited resources.
Neurons in the gut produce a molecule that plays a pivotal role in shaping the gut's immune response during and after inflammation, according to a new study by Weill Cornell Medicine investigators.
A research team led by Dr. Juyeon Jung at the Bio-Nano Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), has developed a nanobody-based technology that can precisely ...